Log inSign up
LANGUAGE en
Menu
STOREE-ReadingHelp centerContactsDelivery chargesABOUT US News
SEARCH
0
Total price
0 USD
PRICES include / exclude VAT
Homepage>BS Standards>11 HEALTH CARE TECHNOLOGY>11.040 Medical equipment>11.040.40 Implants for surgery, prosthetics and orthotics>BS ISO 13019:2018 Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis
immediate downloadReleased: 2018-06-11
BS ISO 13019:2018 Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis

BS ISO 13019:2018

Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis

Format
Availability
Price and currency
English Secure PDF
Immediate download
270.40 USD
You can read the standard for 1 hour. More information in the category: E-reading
Reading the standard
for 1 hour
27.04 USD
You can read the standard for 24 hours. More information in the category: E-reading
Reading the standard
for 24 hours
81.12 USD
English Hardcopy
In stock
270.40 USD
Standard number:BS ISO 13019:2018
Pages:24
Released:2018-06-11
ISBN:978 0 580 89425 1
Status:Standard
DESCRIPTION

BS ISO 13019:2018


This standard BS ISO 13019:2018 Tissue-engineered medical products. Quantification of sulfated glycosaminoglycans (sGAG) for evaluation of chondrogenesis is classified in these ICS categories:
  • 11.040.40 Implants for surgery, prosthetics and orthotics

This document specifies test methods for the quantification of sulfated glycosaminoglycans (sGAG), one of the major extracellular matrix components in articular, meniscal, and elastic cartilages, and tissue-engineered cartilage constructs.


Print